Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer – Results of a phase 1b clinical trial

Authors:

Abstract
No abstract available
Funding Information
  • Boehringer Ingelheim Pharma GmbH und Co. KG

This publication has 14 references indexed in Scilit: